We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Discover Xhance, a unique fluticasone propionate nasal spray for treating nasal polyps and chronic rhinosinusitis in adults. Learn how its Exhalation Delivery System effectively targets inflammation, reduces polyps, and improves symptoms. This guide covers usage, benefits, potential side effects, and important precautions for managing chronic sinus conditions.

Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026

Nasal polyps and chronic rhinosinusitis (CRS) are common, often debilitating conditions that can significantly impact a person's quality of life. Characterized by persistent inflammation of the nasal passages and sinuses, they can lead to a host of uncomfortable symptoms, from persistent congestion and difficulty breathing to a diminished sense of smell and facial pain. For many years, treatment options primarily involved traditional nasal sprays, oral steroids, or surgery. However, advancements in medical science have introduced more targeted therapies, including Xhance (fluticasone propionate) nasal spray, a unique medication designed to deliver corticosteroids effectively to the deeper and higher reaches of the nasal cavity and sinuses.
This comprehensive guide delves into Xhance, exploring its mechanism of action, approved uses, proper administration, potential side effects, and important precautions. We will also provide a detailed overview of nasal polyps and chronic rhinosinusitis, including their symptoms, causes, and diagnostic approaches, empowering you with the knowledge to better understand and manage these challenging conditions with the guidance of your healthcare provider.
Before exploring Xhance in detail, it's crucial to understand the conditions it aims to treat. Nasal polyps and chronic rhinosinusitis are distinct but often co-occurring inflammatory conditions of the nasal and sinus passages.
Nasal polyps are noncancerous, teardrop-shaped growths that form on the lining of your nasal passages or sinuses. They are typically soft, painless, and appear pale grey or pink. While small polyps might not cause any problems, larger polyps or clusters of polyps can block nasal passages, leading to a variety of symptoms. They are often a result of chronic inflammation and are frequently associated with conditions like asthma, allergies, and aspirin sensitivity.
These growths are essentially swollen, inflamed tissue that protrudes from the mucous membranes. They can develop in various locations within the nasal cavity and sinuses, but they are most commonly found where the sinuses open into the nasal cavity. The presence of polyps can obstruct normal airflow and mucus drainage, creating an environment ripe for further inflammation and potential infection.
Chronic rhinosinusitis, often simply called chronic sinusitis, is a persistent inflammatory condition affecting the lining of the nose and paranasal sinuses. It is diagnosed when symptoms last for 12 weeks or longer, despite appropriate medical treatment. CRS can occur with or without nasal polyps. When polyps are present, it is termed Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), and when they are absent, it's Chronic Rhinosinusitis without Nasal Polyps (CRSsNP).
The hallmark of CRS is ongoing inflammation, leading to swelling and mucus build-up in the sinus cavities. This inflammation can be triggered by various factors, including infections (bacterial, fungal, or viral), allergies, structural abnormalities, or immune system dysfunction. The persistent nature of CRS means that the lining of the sinuses remains inflamed and swollen, leading to a cycle of symptoms that significantly affect daily life.
Both nasal polyps and CRS can severely impact a person's quality of life. The constant nasal congestion can disrupt sleep, leading to fatigue and reduced productivity. The loss or reduction of the sense of smell (anosmia or hyposmia) can affect appetite and the enjoyment of food, and in some cases, can even pose safety risks (e.g., inability to smell smoke or gas). Chronic facial pain, pressure, and headaches can be debilitating. Furthermore, the persistent nature of these symptoms can lead to emotional distress, including anxiety and depression, highlighting the need for effective and sustained treatment.
Identifying the symptoms of nasal polyps and chronic rhinosinusitis is the first step toward seeking appropriate medical care. While symptoms can vary in severity, they generally involve a persistent blockage and inflammation within the nasal and sinus passages.
It's important to be aware of signs that symptoms might be worsening or indicating a complication. These can include: severe, localized facial pain; high fever; sudden vision changes; swelling around the eyes; or severe headache. These could signal an acute infection or a more serious condition requiring immediate medical attention.
The development of nasal polyps and chronic rhinosinusitis is often multifactorial, involving a complex interplay of genetic predispositions, environmental factors, and immune system responses.
At the core of both conditions is chronic inflammation of the mucous membranes lining the nasal passages and sinuses. This inflammation is often characterized by a specific type of immune response known as Type 2 inflammation, which involves an overactivity of certain immune cells (like eosinophils) and inflammatory mediators. This persistent inflammatory state leads to swelling, fluid accumulation, and the formation of polyps.
In individuals with Type 2 inflammation, the immune system mistakenly overreacts to perceived threats, leading to a cascade of inflammatory processes. This sustained inflammation damages the delicate lining of the nasal passages and sinuses, disrupting normal mucociliary clearance (the process by which mucus and trapped particles are swept out of the respiratory tract). The impaired clearance then further exacerbates inflammation and can create a fertile ground for infections, perpetuating the cycle.
Several conditions and factors are known to increase the risk of developing nasal polyps and CRS:
Understanding these underlying causes and risk factors is crucial for both diagnosis and developing an effective, personalized treatment plan.
Accurate diagnosis is essential for effective management of nasal polyps and chronic rhinosinusitis. A healthcare provider will typically use a combination of medical history, physical examination, and specialized tests.
The diagnostic process begins with a thorough discussion of your symptoms. Your doctor will ask about the nature, duration, and severity of your nasal congestion, discharge, facial pain, loss of smell, and any other related symptoms. They will also inquire about your medical history, including any allergies, asthma, previous sinus infections or surgeries, and current medications. This helps to paint a comprehensive picture of your condition and rule out other potential causes of your symptoms.
A physical examination will involve a visual inspection of your nasal passages. Your doctor may use a specialized light source and a nasal speculum to look inside your nose for visible polyps, inflammation, and discharge. They might also gently press on your face to check for tenderness over your sinuses.
Nasal endoscopy is a key diagnostic tool. During this procedure, a thin, flexible tube with a camera and light source (endoscope) is gently inserted into your nasal passages. This allows the doctor to visualize the entire nasal cavity and the openings of the sinuses in detail. They can identify the presence, size, and location of nasal polyps, assess the extent of inflammation, and look for any anatomical abnormalities that might contribute to your symptoms. The procedure is usually well-tolerated and can be performed in the office after applying a topical decongestant and anesthetic spray.
A computed tomography (CT) scan of the sinuses is often performed to get a more detailed view of the sinus cavities and surrounding bone structures. A CT scan can reveal the extent of inflammation, the presence and size of polyps that may not be visible during endoscopy, blockages in the sinus drainage pathways, and any structural issues. It is particularly useful for surgical planning or when considering the overall burden of the disease. Unlike X-rays, a CT scan provides cross-sectional images, offering a much clearer picture of the complex anatomy of the sinuses.
Depending on your symptoms and medical history, your doctor may recommend additional tests:
A comprehensive diagnostic approach ensures that your treatment plan is tailored to the specific nature and severity of your condition.
Managing nasal polyps and chronic rhinosinusitis often requires a multi-faceted approach, ranging from conservative measures to advanced medical therapies and surgical interventions. The goal is to reduce inflammation, clear nasal passages, alleviate symptoms, and prevent recurrence.
Corticosteroids are powerful anti-inflammatory medications and form the primary medical treatment for nasal polyps and CRS.
These sprays deliver corticosteroids directly to the nasal lining, reducing inflammation and shrinking polyps with minimal systemic absorption. They are a first-line treatment for long-term management and are effective in many cases. Examples include fluticasone propionate, mometasone furoate, and budesonide.
For more severe cases or during acute exacerbations, a short course of oral corticosteroids (e.g., prednisone) may be prescribed. These are highly effective at reducing inflammation and shrinking polyps rapidly. However, due to potential systemic side effects, oral steroids are generally used for short durations and are not suitable for long-term maintenance.
For individuals with severe CRSwNP that does not respond to conventional treatments or surgery, biologic medications may be an option. These injectable drugs target specific inflammatory pathways (e.g., Type 2 inflammation) in the immune system. Biologics, such as dupilumab, mepolizumab, and omalizumab, have shown significant efficacy in reducing polyp size, improving symptoms, and decreasing the need for oral steroids and surgery.
When medical treatments are insufficient, surgery may be considered. Endoscopic sinus surgery (ESS) is a minimally invasive procedure performed to remove nasal polyps, clear blocked sinus passages, and improve drainage. During ESS, an endoscope is used to guide instruments, allowing the surgeon to precisely remove polyps and widen sinus openings. While surgery can provide significant relief, nasal polyps often recur, even after successful removal, necessitating ongoing medical management.
Xhance (fluticasone propionate) nasal spray represents an important advancement in the medical treatment of nasal polyps and chronic rhinosinusitis. Its unique delivery system sets it apart from conventional nasal corticosteroid sprays.
Xhance contains fluticasone propionate, a potent synthetic corticosteroid. Corticosteroids are known for their strong anti-inflammatory properties, which are crucial for reducing the swelling and inflammation associated with nasal polyps and chronic rhinosinusitis.
The key distinguishing feature of Xhance is its innovative Exhalation Delivery System (EDS). This system is designed to overcome the limitations of traditional nasal sprays, which often struggle to reach the deeper and higher areas of the nasal cavity and sinuses where polyps and inflammation are often located.
Traditional nasal sprays rely on inhalation to draw the medication into the nasal passages. However, this often results in most of the medicine settling in the front of the nose, with limited penetration into the ethmoid and sphenoid sinuses, or the superior aspects of the nasal cavity where polyps frequently originate. Xhance's EDS addresses this challenge through a unique delivery mechanism:
By delivering the anti-inflammatory medication directly to these hard-to-reach areas, Xhance aims to more effectively reduce inflammation, shrink polyps, and alleviate symptoms of CRS. This targeted delivery optimizes the therapeutic effect of fluticasone propionate where it is most needed.
Xhance is approved by the U.S. Food and Drug Administration (FDA) for:
Its approval for CRS, even in the absence of polyps, highlights its ability to address the underlying inflammation that characterizes the condition.
Clinical studies have demonstrated the efficacy of Xhance in treating its approved indications. In trials involving adults with nasal polyps, Xhance significantly reduced polyp size, improved nasal congestion, and enhanced the sense of smell compared to placebo. For patients with chronic rhinosinusitis, Xhance has been shown to reduce symptoms such as nasal congestion and facial pain, and improve overall quality of life measures. These improvements are attributed to the targeted delivery of fluticasone propionate, leading to a more profound anti-inflammatory effect in the affected areas.
Correct usage of Xhance is critical to ensure the medication reaches the intended areas and provides optimal therapeutic benefit. It's essential to follow your doctor's instructions and the detailed instructions provided with the device.
Here’s a general guide for using Xhance, but always refer to the specific instructions from your healthcare provider and the product leaflet:
The typical dosage for Xhance is two sprays into each nostril once or twice daily, as prescribed by your doctor. It is crucial not to exceed the prescribed dose. Your doctor will determine the most appropriate dosage based on your condition and response to treatment.
Adhering to the proper administration technique and dosage schedule is paramount for maximizing the benefits of Xhance and effectively managing your nasal polyps and chronic rhinosinusitis.
Like all medications, Xhance can cause side effects, although not everyone experiences them. It's important to be aware of both common and more serious potential effects and to discuss any concerns with your healthcare provider.
These side effects are typically mild, often resolve on their own, and are generally related to the local application of the spray:
While rare, some side effects can be more serious and warrant immediate medical attention or discussion with your doctor:
It's important to inform your doctor about all medications you are taking, including over-the-counter drugs, herbal supplements, and other nasal sprays. Xhance contains fluticasone propionate, which is metabolized by the CYP3A4 enzyme in the liver. Strong inhibitors of CYP3A4, such as ritonavir (used for HIV treatment) and ketoconazole (an antifungal), can significantly increase the systemic exposure to fluticasone, potentially leading to increased systemic corticosteroid side effects. Your doctor may need to adjust your dosage or monitor you more closely if you are taking such medications.
Always discuss your complete medical history and current medication list with your doctor or pharmacist to identify any potential interactions or contraindications before starting Xhance.
Before starting Xhance, and throughout your treatment, it's crucial to be aware of specific precautions and warnings to ensure safe and effective use. Always have an open discussion with your healthcare provider about your medical history and any concerns.
Inform your doctor if you have, or have had, any of the following medical conditions, as Xhance may not be suitable or may require careful monitoring:
If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of using Xhance with your healthcare provider. While nasal corticosteroids generally have low systemic absorption, the potential effects on a developing fetus or nursing infant are important considerations. Your doctor will weigh the potential benefits of treatment against any potential risks.
Xhance is approved for use in adults only. It is not approved for children, and its safety and efficacy in the pediatric population have not been established. Nasal corticosteroids can potentially affect growth rate in children, a factor that is carefully considered for pediatric nasal sprays.
If you are currently taking oral corticosteroids and are transitioning to Xhance, you may be at risk for adrenal insufficiency. Your doctor will carefully manage this transition, gradually reducing your oral steroid dose. During and after this transition, you may experience symptoms of corticosteroid withdrawal or exacerbation of underlying conditions (e.g., joint pain, muscle pain, depression, fatigue). If you experience stress (e.g., trauma, surgery, infection) during this period, your doctor may temporarily increase your oral steroid dose.
Always use Xhance exactly as prescribed by your doctor and do not adjust your dosage or stop the medication without consulting them. Regular follow-up appointments are important to monitor your condition and assess for any side effects or complications.
Knowing when to seek medical advice is crucial for managing nasal polyps and chronic rhinosinusitis effectively and safely. While Xhance can be a highly effective treatment, ongoing professional guidance is essential.
Your healthcare provider is your best resource for personalized medical advice. Do not hesitate to contact them with any questions or concerns regarding your condition or treatment with Xhance.
While Xhance provides a targeted therapeutic option, managing nasal polyps and chronic rhinosinusitis is an ongoing process that often involves a combination of medical treatment and lifestyle adjustments. Empowering yourself with good management practices can significantly improve your quality of life and potentially reduce the frequency or severity of symptoms.
Living with nasal polyps and CRS requires a proactive approach. By working closely with your healthcare team and integrating these management strategies into your daily routine, you can significantly improve your symptoms, enhance your overall well-being, and maintain better nasal health.
Here are some common questions about Xhance that patients often ask:
Yes, Xhance contains fluticasone propionate, which is a corticosteroid. Corticosteroids are powerful anti-inflammatory medications. Xhance delivers this steroid directly to the nasal passages and sinuses to reduce inflammation and shrink polyps.
Some individuals may start to notice improvements in symptoms like nasal congestion within a few days of starting Xhance. However, for the full therapeutic effect, especially for significant reduction in polyp size and improvement in the sense of smell, it can take several weeks of consistent use. It's important to continue using the medication as prescribed even if immediate relief isn't felt.
Xhance is often prescribed for the long-term management of nasal polyps and chronic rhinosinusitis. Your doctor will determine the appropriate duration of treatment based on your individual condition and response. Regular follow-up appointments are important to monitor long-term use and assess for any potential side effects.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.
No, Xhance is not safe for everyone. It is approved for adults only and should not be used in children. It may also be contraindicated or require careful monitoring in individuals with certain medical conditions, such as glaucoma, cataracts, recent nasal surgery, or active infections. Always discuss your complete medical history with your doctor before starting Xhance.
Xhance can effectively shrink nasal polyps, reduce inflammation, and alleviate symptoms of nasal polyps and chronic rhinosinusitis. However, like many treatments for these chronic conditions, it manages the symptoms and the underlying inflammation rather than providing a permanent cure. Nasal polyps can often recur, even after successful medical or surgical treatment, necessitating ongoing management.
You should always consult your doctor or pharmacist before using Xhance with any other nasal sprays, including over-the-counter decongestants or saline sprays. Combining certain nasal sprays might lead to increased side effects or reduced effectiveness. Generally, saline rinses can be used prior to Xhance to clear the nasal passages.
Nasal polyps and chronic rhinosinusitis are persistent and often challenging conditions that can profoundly impact daily life. The constant battle with congestion, facial pain, and a diminished sense of smell can be frustrating and debilitating. However, with advancements in medical science, effective treatments like Xhance are available to help manage these conditions.
Xhance, with its innovative Exhalation Delivery System, offers a targeted approach to delivering the anti-inflammatory power of fluticasone propionate to the deeper and higher regions of the nasal cavity and sinuses, areas often difficult for traditional nasal sprays to reach. This unique mechanism allows for more effective reduction of inflammation and shrinkage of polyps, leading to significant symptom relief and an improved quality of life for many adults.
Understanding your condition, recognizing the symptoms, and knowing your treatment options are crucial steps in your health journey. While Xhance provides a powerful tool, it is paramount to use it correctly, be aware of potential side effects, and maintain open communication with your healthcare provider. Your doctor is your most valuable partner in developing a personalized treatment plan that addresses your specific needs, monitors your progress, and ensures the safe and effective use of medication.
By embracing a proactive approach to your nasal health and adhering to professional medical guidance, you can effectively manage nasal polyps and chronic rhinosinusitis, breathing easier and experiencing a renewed sense of well-being.
Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026